Back to top

‘If it ain’t broke...’ An HIV specialist looks at the question from both sides

For some people with HIV, especially long-term or lifelong survivors, they might be fine—comfortable, even—with the treatment that they’ve been on for many years, even if the drugs have fallen out of favor with the U.S. Department of Health and Human Services, which issues treatment recommendations.

An infectious disease specialist and faculty member at Chicago’s Northwestern University School of Medicine, Jo-Ann Jose, MD, MPH, is medical director of Vivent Health + TPAN. (Vivent Health acquired TPAN, the founding publisher of POSITIVELY AWARE, in 2023.) She also provides the Doctor’s Comments on the individual drug pages of this year’s HIV Drug Guide. Drawing on her eight years of treating people with HIV, Dr. Jose talked about what patients and care providers should consider when discussing changing an older HIV drug regimen.

If it’s been working for years, what’s wrong with being on the same treatment?

Sometimes there is nothing wrong with that. If someone’s been on a regimen for a long time, it’s working well for them and there are no data on side effects that’s concerning, then it might be perfectly appropriate to continue an older regimen if it works well. I think it’s not always the right answer to switch regimens, but there are a lot of situations in which the right answer might be to consider switching the regimen.

He was like, Well, I trusted the person who put me on this,  I’m not sure I trust anyone who would tell me to change it.  That’s a really basic thing.

Most commonly, that comes about when someone is on an older regimen that has some pretty significant side effects that are well known at the time, but information emerged only after the drug became widely available.

We have a couple of good examples of that. Atripla [the first all-in-one, single-tablet regimen, approved by the FDA in 2006], which a lot of people were on at one time, has some interesting mental health side effects that were only discovered much later. We knew about the very vivid dreams and even some of the kind of equilibrium [balance] issues that some people could get, but it was found in a study later to have some associations with mood symptoms and possibly even suicidal ideation. For that reason, you might talk with someone and say, You’ve been on this drug for a long time. It works well for you in terms of controlling your HIV, but not only is there this association with mood symptoms, but one of the components of Atripla is associated with long-term bone issues and possibly some long-term kidney issues. Should we minimize the potential harm from this medicine by switching you to something that doesn't have the same side effects?

Here’s another example. Lots of people are on a regimen that contains either ritonavir or cobicistat. These are boosters—they work with protease inhibitors [a class of HIV drugs] to raise the level of the protease inhibitor. But the boosters work on lots of other things. They work on over-the-counter drugs, herbal supplements and other, non-medical things that you might take. 

I might have a conversation with a patient: There are lots of options that don’t involve this type of booster drug that could put you at risk for having an interaction. Should we think about switching you?

I want to emphasize that this should always be a decision that you and your provider make together. This is a shared decision. This is not the provider telling you what to do. That should never be how your care is done. This is a discussion where the provider shares their concerns, and you share yours: I’m nervous about this. What will happen when I switch? Will I have side effects? What if something happens? Make a plan for all those contingencies if you are going to decide to switch.

What questions should the person ask their doctor, or maybe even ask themselves?

For people who are living with any chronic disease where they take medicine on a regular basis, it’s important to know how it works and is it doing its job. With HIV meds, the most obvious way to do that is to look at the viral load. If the medicine is working the way it's supposed to, your viral load should be undetectable. If it’s not undetectable, then a conversation needs to be had about why that is. Is it that the medicine isn’t working? Maybe there’s an imperfection in how it’s being taken that we can easily correct. Is there perhaps an interaction that nobody is aware of that’s interfering with the ability to keep the HIV under control?

Sometimes a new doctor might question your old regimen.

Your new doctor might ask, Why are you on this? I think that conversation is already a fraught experience. You’ve changed providers, that’s never an easy experience. You have to tell them about your life and your circumstances. There’s often a sense of bereavement as well for the previous provider you left behind or who retired, moved or whatever. That emotion is a valid thing to feel. It’s important for providers to understand that there may be this bereavement for people when they have to change providers.

If your provider is asking you about changing your regimen, you should ask them what is their rationale. I think that’s well within what I would expect a patient to ask me. If I find that someone is on a regimen that I might have some concerns about, the way I phrase it is, I want to talk to you about some things about this medicine. Would this be a good time to do that? And if someone’s feeling overwhelmed by meeting a new provider, they may just say no, and I’ll respect that. I’ll make a note to come back and maybe talk about it at the next visit. If I’m given permission, we’ll talk it through. At this point, the question is not, What will control your HIV? The question is, Would you be open to kind of talking through some of our other options? That’s where the conversation should go.

New and coexisting conditions can emerge, especially as people age—high blood pressure, diabetes—how do they factor in?

As we’re accumulating more medical conditions, we are also accumulating more medicine, and that’s becoming more and more common. Polypharmacy is when you are taking more than five medications for different conditions. There are studies that show that people living with HIV, regardless of their age, are more likely to experience polypharmacy. It becomes important to think about how these different drugs are dealing with each other. Are there side effects of HIV medicines around things like cardiovascular risk? There’ve been questions about abacavir [brand name Ziagen, and a component of the all-in-one daily medication Triumeq] for a long time. The data are complex and nuanced, but overall, we can probably conclude that there is some increased cardiovascular risk associated with abacavir. If I know that you are more likely to experience cardiovascular events, we also know that there’s pretty good evidence to suggest, based on data from the REPRIEVE clinical trial, that if I give you a statin medication, I can moderate that risk. If it’s so important that I would give you another medicine for a preventative reason, why would I keep you on an HIV regimen that could potentially increase your cardiovascular risk?

How am I going to know about drug interactions?

I run an interaction check. There’s an online tool, HIV Liverpool [hiv-druginteractions.org, operated by the University of Liverpool] that is the best way to check for drug interactions between HIV and non-HIV drugs. I’ll check there, especially if I know that there’s a high risk for interactions, perhaps if the person is on a booster, like cobicistat [brand name Tybost] or ritonavir [brand name Norvir], or if there’s a lot of medications the patient is on. I’ll run the list of medications, print out the reports and I’ll go over it with them. I’ll explain how to read the report so that they know what we are looking at.

Is cost ever a reason why people are reluctant to change?

It is. Different insurance plans have different copays that they impose on different medicine. Another complication is that different insurance plans use different formularies. Your insurance plan’s formulary may not include a certain medicine. That information changes all the time. And then there are drug companies that may decide that they don’t want to manufacture this drug anymore.

It’s important to know what resources are available. Many drug companies have a prescription assistance program or a copay assistance program that you can access. A case manager can do that for you, or you can do it online. Also, tell your doctor so they can get you to the correct resource. [Listings of patient assistance programs, co-pay programs and other resources can be found here or in the HIV Drug Guide starting on page 60.]

What are some of the reasons a person might want to hold onto their old regimen?

Sometimes there’s an emotional attachment to that first regimen that worked because all the others previous medicines were so difficult to tolerate. There’s also fear based on that experience—If I change medicine, will I go back to having those awful side effects from before? That is a fair and legitimate feeling. I’m careful to respect that, because I think that is a traumatic experience.

Another reason has to do with trust. Often these discussions are happening when there’s a change in provider or a change in location or a change in life. Now you have to establish a relationship with a new doctor and a new system. That’s a time of low trust. It’s hard to trust someone you’ve literally just met a few minutes ago. The kind of interaction I have as a provider with you can inform whether or not you feel comfortable with my recommendation for changing medications. If I come in really hard and say, I need to get you off this medicine, that’s much different from, Can we talk about some of these side effects and explore whether you’d be open to a change? Here’s why I’m recommending it. No pressure to do this, but I’d love to have the conversation about your experience.

A lot of times I’m meeting someone for the first time, and I will see that they’ve been on the same regimen for a while. I’ll notice that there may be evidence of harm. I’ll give you an example of one patient who has given me permission to share his story. I had this lovely patient who was on a regimen that I found eccentric. It was a lot of pills, multiple times a day, but he did not want it changed. I looked at the notes of his previous providers: He is quite adamant—I do not want this changed. But nobody had ever asked him why. When I met him for the first time, he wasn’t quite sure about me. I asked if we could talk about it. He said he’d rather not. I said, Okay, we’ll talk about it next time. When he came back for the next visit, I was like, I’m just curious. I approached it from a place of curiosity. I would strongly recommend that every provider do that.

People do things for a reason that makes sense to them. It may not make sense to you, it may not be what you would do, but that’s the whole point. Each person is a universe unto themselves, and they have the right to make their own decisions. If we approach it from curiosity and not judgment, then we can find out why, and that makes us more persuasive. It also might make us decide that we don’t want to push for a change, because their reason is a good one, and there’s no reason to interfere with it.

For people who are living with any chronic disease where they take medicine on a regular basis, it’s important to know how it works and is it doing its job.

I saw that he had had a cardiac event. He was on abacavir, which as I said is associated with cardiovascular risk. There were also some kidney issues. So, I just asked, and what came out in conversation was that there had been a lot of trauma with health systems. There had been a lot of providers who made changes without consulting him or talking to him about what he would like to do. This regimen had been prescribed by a physician he had high trust in. And since then, he had cycled through several other physicians. He was like, Well, I trusted the person who put me on this, I’m not sure I trust anyone who would tell me to change it. That’s a really basic thing. But it’s also something I can work on, by building trust and by explaining and giving him the room to make decisions with all of the information that I can put at his disposal. About three months later, he came back for another visit, and he did let me significantly simplify his regimen. He immediately experienced a reduction in side effects that he had not even realized were side effects. He was really happy with the change. But it took time, and it took the building of trust. We should always be building trust. It was a good reminder to, first of all, be curious rather than judgmental, and then secondly, to give people the space and the time to absorb what you are saying and interact with it the way that they want to.   

Unknown ingredients: Herbal supplements and semaglutide

Herbal supplements are not regulated by the FDA. They have a list of ingredients, but they also have inactive ingredients that are quite hard to figure out what those are. So it’s really hard for you yourself to get reliable information on whether or not this is going to interact. It can be quite difficult for your doctor to figure out if it’s something that’s going to interact. because they’re not regulated by the FDA, so you don’t actually know what’s in them. I think what I would tell people to do is to take your herbal supplement to your doctor, show them the packaging so they can look at it and see what they think. Sometimes they will give you an answer that will not make you happy, which is, I don’t actually know if this is going to cause a problem, so just monitor for problems and let me know if you experience any.  I understand that’s not a satisfactory answer.

There’s another one, the compounded semaglutide products. So this is really common. People are accessing compounded semaglutide, because actual semaglutide is very hard to access, and weight loss is important to a lot of people. They are accessing these services online, like subscription services. I have zero information about what is actually in compounded semaglutide—it’s not FDA regulated. It might be fine, but it might not be. There’s no way for me to know. And if you’re on a medicine that contains a booster, this is something you want to be quite careful about, because we don’t actually know anything about what's in those compounded formulations.

—Jo-Ann Jose, MD, MPH